|
業務類別
|
Biotechnology |
|
業務概覽
|
Omeros Corp is an inventive, commercial-stage biotechnology company that discovers and develops first-in-class protein and small-molecule therapeutics for large-market and orphan indications, with particular emphasis on complement-mediateddiseases, cancers, and addictive or compulsive disorders. The company's clinical-stage development programs include: narsoplimab, its antibody targeting mannan-binding lectin-associated serine protease 2 (MASP-2), the effector enzyme of the lectin pathway of complement; OMS1029, its long-acting antibody targeting MASP-2; and OMS527, its phosphodiesterase 7 (PDE7) inhibitor program. |
| 公司地址
| 201 Elliott Avenue West, Seattle, WA, USA, 98119 |
| 電話號碼
| +1 206 676-5000 |
| 傳真號碼
| +1 206 676-5005 |
| 公司網頁
| https://www.omeros.com |
| 員工數量
| 175 |
| Mr. Peter W. Williams |
Vice President, Human Resources |
-- |
31/03/2026 |
| Dr. Gregory A. Demopulos,M.D. |
Chairman of the Board, President and Chief Executive Officer |
美元 972.53K |
30/04/2026 |
| Dr. George A. Gaitanaris, M.D.,PhD |
Vice President, Science and Chief Scientific Officer |
-- |
31/03/2026 |
| Dr. J. Whitaker, J.D.,M.D. |
Vice President, Clinical Development |
-- |
31/03/2026 |
| Dr. Catherine A. Melfi, PhD |
Vice President, Regulatory Affairs and Quality Systems and Chief Regulatory Officer |
-- |
31/03/2026 |
| Mr. David W. Ghesquiere |
Vice President and Chief Business Development Officer |
-- |
31/03/2026 |
| Dr. Andreas Grauer, M.D. |
Vice President and Chief Medical Officer |
-- |
31/03/2026 |
| Ms. Nadia Dac |
Vice President and Chief Commercial Officer |
-- |
31/03/2026 |
| Mr. Peter B. Cancelmo |
Vice President, General Counsel and Corporate Secretary |
美元 489.48K |
31/03/2026 |
| Dr. Mariana N. Dimitrova, PhD |
Vice President, Chemistry, Manufacturing and Controls |
-- |
31/03/2026 |
| Mr. David J. Borges |
Vice President, Finance, Chief Accounting Officer, Principal Financial Officer and Treasurer |
美元 325.60K |
31/03/2026 |
|
|
| Mr. Arnold C. Hanish |
Independent Director |
30/04/2026 |
| Dr. Leroy E. Hood,M.D.,Ph. |
Independent Director |
30/04/2026 |
| Dr. Gregory A. Demopulos,M.D. |
Chairman of the Board, President and Chief Executive Officer |
30/04/2026 |
| Mr. Thomas J. Cable |
Lead Independent Director |
30/04/2026 |
| Dr. Peter A. Demopulos,M.D. |
Director |
30/04/2026 |
| Dr. Rajiv Shah, M.D. |
Independent Director |
30/04/2026 |
| Dr. Thomas F. Bumol, PhD |
Independent Director |
30/04/2026 |
| Ms. Diana T. Perkinson |
Independent Director |
30/04/2026 |
|
|
|
|
